Biopharma and Pharma are major end-use industries for TCP market. It includes Vaccines, drugs, enzymes, tissues, gene therapies, cell therapies and others are some examples of the product from the industries. These products require a lower temperature for shipping. In 2020, due to the COVID-19 pandemic, the demand for the COVID-19 vaccine, cell and gene therapies, other flu vaccines have increased significantly. The growing demand for pharmaceutical products is driving TCP market during the forecast period. Moreover, utilisation of advance insulation material in packaging and increasing demand of reusable container due to lower environment impact are other driving factors for TCP market.
Temperature Controlled Packaging Solutions Market worth $80.1 billion by 2026 - Exclusive Report by MarketsandMarkets Temperature Controlled Packaging Solutions Market by Type (Active, Passive), Product, Usability (Single, Reuse), Revenue type (Product, Service), End-Use Industry (Pharma and Biopharma) & Region - Trends and Forecasts Up to 2026 , published by MarketsandMarkets, the market size is estimated to be USD 34.4 billion in 2021 and is projected to reach USD 80.1 billion by 2026, at a CAGR of 18.4% between 2021 and 2026.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=5227701
Browse in-depth TOC on
120 - Tables
View Detailed Table of Content Here: https://www.marketsandmarkets.com/Market-Reports/temperature-controlled-packaging-solutions-market-5227701.html
Biopharma and Pharma are major end-use industries for TCP market. It includes Vaccines, drugs, enzymes, tissues, gene therapies, cell therapies and others are some examples of the
/PRNewswire/ The global cold chain market size is estimated to reach USD 628.26 billion by 2028, according to a new study by Grand View Research, Inc.,.